Open AccessTransarterial therapy: An evolving treatment modality of hepatocellular carcinoma
Author(s) -
Khalid Jazieh,
Mohammad Arabi,
Azzam Khankan
Publication year - 2014
Publication title -
the saudi journal of gastroenterology/saudi journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.608
H-Index - 32
eISSN - 1998-4049
pISSN - 1319-3767
DOI - 10.4103/1319-3767.145315
Subject(s) - medicine , hepatocellular carcinoma , liver transplantation , asymptomatic , radiofrequency ablation , transarterial embolization , embolization , liver cancer , curative treatment , radiology , cancer , treatment modality , surgery , ablation , disease , transplantation
Liver cancer is the fifth most common cancer in men, the seventh most common in women, and the third most common cause of death from cancer worldwide. Only 30-40% of liver cancer patients present early enough to undergo curative treatments such as surgery or liver transplantation. Local treatment with radiofrequency ablation or ethanol injection is often reserved for non-surgical candidates with early stages of disease. Transarterial embolization has become a widely accepted treatment for asymptomatic patients with unresectable lesions. This review discusses in details the three major forms of transarterial therapies: Bland embolization, chemoembolization, and radioembolization.